Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies.

Journal of biochemical and molecular toxicology - 1 Jul 2023

Chang Defeng, Li Lanlan, Xu Zhongqing, Chen Xiaohong

Abstract excerpt

Data retrieved from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases can reveal important information behind molecular biomarkers and their associated oncogenesis. Therefore, this study was based on in silico predictions and in vitro experiments to explore regulatory network associated with breast carcinogenesis. The breast cancer (BC)-related data sets were retrieved from GEO database,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Cycle Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasms

Share to Phenotype

Source

Identifiers

PMID: 37016468
DOI: 10.1002/jbt.23358

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies.PMID 37016468Read ↗

Comprehensive tissue-specific gene set enrichment analysis and transcription factor analysis of breast cancer by integrating 14 gene expression datasets.Semantic proximity Read ↗

Integrated transcriptome interactome study of oncogenes and tumor suppressor genes in breast cancerSemantic proximity Read ↗

Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.Semantic proximity Read ↗

Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer HypoxiaSemantic proximity Read ↗

Breast cancer biomarkers identified in the Gene Expression Omnibus and The Cancer Genome AtlasSemantic proximity Read ↗

Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer.Semantic proximity Read ↗

Identification of ATFs in Human Breast Cancer by Integrated Bioinformatic AnalysisSemantic proximity Read ↗

The Role of PAX2 in Breast Cancer: A Study Based on Bioinformatics Analysis and in Vitro ValidationSemantic proximity Read ↗

Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasetsSemantic proximity Read ↗

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progressSemantic proximity Read ↗

<i>EGRI</i> and <i>FOSB</i> gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapySemantic proximity Read ↗

Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.